News - October 31, 2022

Remap Consulting survey on the new EU HTA regulation

Remap Consulting has launched a short survey to gather feedback from biotech, pharmaceutical and medical device companies on the new EU HTA regulation, and how prepared they are for it.

Remap is eager to get feedback from small and mid-sized companies as part of the survey, and will share a consolidated report of the responses to survey respondents to allow benchmarking against other companies.

If you would like to take part in the survey you can use the following link:

Alternatively, please contact Charlie ( if you would like more information.